These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37239783)

  • 1. Cost-Effectiveness of Cerebrolysin after Ischemic Stroke: Secondary Analysis of the CARS Study.
    Strilciuc S; Radu C; Grad DA; Stan AD; Vladescu C; Buzoianu AD; Muresanu D
    Healthcare (Basel); 2023 May; 11(10):. PubMed ID: 37239783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of Mechanical Thrombectomy More Than 6 Hours After Symptom Onset Among Patients With Acute Ischemic Stroke.
    Peultier AC; Pandya A; Sharma R; Severens JL; Redekop WK
    JAMA Netw Open; 2020 Aug; 3(8):e2012476. PubMed ID: 32840620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety, and cost-effectiveness analysis of Cerebrolysin in acute ischemic stroke: A rapid health technology assessment.
    Wan M; Yang K; Zhang G; Yang C; Wei Y; He Y; Jiang X
    Medicine (Baltimore); 2024 Mar; 103(13):e37593. PubMed ID: 38552072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of Endovascular Stroke Therapy: A Patient Subgroup Analysis From a US Healthcare Perspective.
    Kunz WG; Hunink MG; Sommer WH; Beyer SE; Meinel FG; Dorn F; Wirth S; Reiser MF; Ertl-Wagner B; Thierfelder KM
    Stroke; 2016 Nov; 47(11):2797-2804. PubMed ID: 27758942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifetime quality of life and cost consequences of delays in endovascular treatment for acute ischaemic stroke: a cost-effectiveness analysis from a Singapore healthcare perspective.
    Ni W; Kunz WG; Goyal M; Ng YL; Tan K; De Silva DA
    BMJ Open; 2020 Sep; 10(9):e036517. PubMed ID: 32948553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world patient-level cost-effectiveness analysis of omalizumab in patients with severe allergic asthma treated in four major medical centers in Turkey.
    Tugay D; Top M; Aydin Ö; Bavbek S; Damadoğlu E; Öner Erkekol F; Koca Kalkan I; Kalyoncu AF; Karakaya G; Oğuzülgen IK; Türktaş H; Abraham I
    J Med Econ; 2023; 26(1):720-730. PubMed ID: 37129881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.
    Shah BD; Smith NJ; Feng C; Jeyakumar S; Castaigne JG; Faghmous I; Masouleh BK; Malone DC; Bishop MR
    Adv Ther; 2022 Aug; 39(8):3678-3695. PubMed ID: 35727476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of tissue-type plasminogen activator in the 3- to 4.5-hour time window for acute ischemic stroke.
    Tung CE; Win SS; Lansberg MG
    Stroke; 2011 Aug; 42(8):2257-62. PubMed ID: 21719767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the cost-effectiveness of percutaneous closure of a patent foramen ovale versus medical management in patients with a cryptogenic stroke: from the UK payer perspective.
    Hildick-Smith D; Turner M; Shaw L; Nakum M; Hartaigh BÓ; Evans RM; Rhodes JF; Sondergaard L; Kasner SE
    J Med Econ; 2019 Feb; 22(2):131-139. PubMed ID: 30424680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland.
    Soini E; Virtanen O; Väätäinen S; Briere JB; Bowrin K; Millier A
    Adv Ther; 2020 Jul; 37(7):3348-3369. PubMed ID: 32519113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of patent foramen ovale closure versus medical therapy alone after cryptogenic stroke.
    Shijoh Y; Saito S; Dai Z; Ohde S
    PLoS One; 2022; 17(6):e0268690. PubMed ID: 35657973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Cost-Effectiveness of Mechanical Thrombectomy Beyond 6 Hours Following Advanced Imaging in the United Kingdom.
    Peultier AC; Redekop WK; Allen M; Peters J; Eker OF; Severens JL
    Stroke; 2019 Nov; 50(11):3220-3227. PubMed ID: 31637975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation.
    Clarke A; Pulikottil-Jacob R; Grove A; Freeman K; Mistry H; Tsertsvadze A; Connock M; Court R; Kandala NB; Costa M; Suri G; Metcalfe D; Crowther M; Morrow S; Johnson S; Sutcliffe P
    Health Technol Assess; 2015 Jan; 19(10):1-668, vii-viii. PubMed ID: 25634033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials.
    Guekht A; Vester J; Heiss WD; Gusev E; Hoemberg V; Rahlfs VW; Bajenaru O; Popescu BO; Doppler E; Winter S; Moessler H; Muresanu D
    Neurol Sci; 2017 Oct; 38(10):1761-1769. PubMed ID: 28707130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women.
    Le KD; Vuong LN; Ho TM; Dang VQ; Pham TD; Pham CT; Norman RJ; Mol BWJ
    Hum Reprod; 2018 Oct; 33(10):1907-1914. PubMed ID: 30239784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of percutaneous closure of a patent foramen ovale compared with medical management in patients with a cryptogenic stroke: from the US payer perspective.
    Volpi JJ; Ridge JR; Nakum M; Rhodes JF; Søndergaard L; Kasner SE
    J Med Econ; 2019 Sep; 22(9):883-890. PubMed ID: 31025589
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical Efficacy of Cerebrolysin and Cerebrolysin plus Nootropics in the Treatment of Patients with Acute Ischemic Stroke in Vietnam.
    Tran L; Alvarez XA; Le HA; Nguyen DA; Le T; Nguyen N; Nguyen T; Nguyen T; Vo T; Tran T; Duong C; Nguyen H; Nguyen S; Nguyen H; Le T; Nguyen M; Nguyen T
    CNS Neurol Disord Drug Targets; 2022; 21(7):621-630. PubMed ID: 34414874
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.